An advanced device for better insulin delivery in diabetes management
A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy
This study is working on a new way to deliver insulin for people with diabetes that could help reduce skin irritation and make insulin devices last longer, so you can have a better experience managing your condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10928819 on NIH RePORTER |
What this research studies
This research focuses on improving the technology used for delivering insulin to patients with diabetes. It aims to address issues related to tissue damage caused by preservatives in current insulin formulations, which can limit the effectiveness of insulin delivery devices. By developing a new inline platform, the research seeks to extend the wear time of insulin delivery devices, aligning them with the longer-lasting continuous glucose monitors. This could potentially reduce inflammation and improve the overall experience for patients managing their diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who require insulin therapy and are experiencing issues with current insulin delivery methods.
Not a fit: Patients who do not use insulin or those with diabetes types that do not require insulin therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective insulin delivery methods, enhancing diabetes management for patients.
How similar studies have performed: Previous research has shown promise in improving insulin delivery technologies, but this approach aims to tackle specific challenges that have not been fully addressed before.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Klueh, Ulrike — Wayne State University
- Study coordinator: Klueh, Ulrike
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.